Old Web
English
Sign In
Acemap
>
Paper
>
PO-0236 HDR monotherapy for low and intermediate risk prostate cancer in one or two fractions
PO-0236 HDR monotherapy for low and intermediate risk prostate cancer in one or two fractions
2021
V. A. Biryukov
A. A. Obukhov
N. B. Borysheva
O.G. Lepilina
D.B. Sanin
N. V. Mikhailovsky
O B Karyakin
S.A. Ivanov
A. D. Kaprin
Keywords:
Internal medicine
intermediate risk
Oncology
Medicine
Prostate cancer
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]